PATIENTS CARE ABOUT CURES, NOT CONFLICT OF INTEREST
More than a third of doctors who sit on review boards overseeing the integrity of clinical trials do not bother to disclose a financial stake in the outcome, a study in the New England Journal of Medicine has shown. However this does not shock cancer patients. In the same journal another study found that 80% were “not worried at all” if a doctor profited from a tested drug. In fact, most patients said that they opposed bans on such relationships. The author of the study said that this was quite understandable since participants in clinical trials “are very vulnerable, have a serious problem and want someone to care for it.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
After 49 years, SCOTUS strikes down Roe v Wade, abolishing a constitutional right to abortion
The US Supreme Court has struck down two of the most famous decisions in American history, Roe v. Wade and...
Fallen stem cell hero convicted in Swedish court
Once hailed as a stem cell technology pioneer, Italian surgeon Paolo Macchiarini has been convicted of causing bodily harm and...
Hollywood actress explains why she chose surrogacy: ‘I was terrified’
Hollywood starlet Jamie Chung, 39, surprised her fans last year when she and her husband announced the birth of twins....
First legal assisted suicide in Italy
Italy’s parliament is still debating the details of legal assisted suicide. However, last Thursday the first Italian to take advantage...
Re-examining autonomy
The buzzword cutting through the noisy controversy over the US Supreme Court’s repeal of Roe v. Wade is “reproductive autonomy”....
World swimming authority takes conservative stand on gender inclusion
Swimming's world governing body, FINA, has backed a new policy on gender inclusion which will stop most trans women swimmers...